Bio-Rad Laboratories PE Ratio 2010-2022 | BIO.B

Current and historical p/e ratio for Bio-Rad Laboratories (BIO.B) from 2010 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Bio-Rad Laboratories PE ratio as of December 01, 2022 is 28.64.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Bio-Rad Laboratories PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2022-12-01 404.66 9.94
2022-09-30 418.65 $40.73 10.28
2022-06-30 471.62 $76.57 6.16
2021-12-31 722.91 $140.07 5.16
2021-09-30 759.91 $220.47 3.45
2021-06-30 640.00 $134.15 4.77
2021-03-31 579.38 $135.98 4.26
2020-12-31 574.15 $126.32 4.55
2020-09-30 508.00 $116.82 4.35
2020-06-30 436.97 $64.50 6.77
2020-03-31 351.32 $52.21 6.73
2019-12-31 369.60 $58.23 6.35
2019-09-30 340.54 $12.04 28.28
2019-06-30 306.18 $29.61 10.34
2019-03-31 303.00 $18.62 16.27
2018-12-31 230.00 $11.65 19.74
2018-09-30 297.67 $41.85 7.11
2018-06-30 285.75 $33.87 8.44
2018-03-31 250.90 $25.17 9.97
2017-12-31 238.25 $3.81 62.53
2017-09-30 228.01 $0.79 288.62
2017-06-30 225.00 $-112.69 0.00
2017-03-31 199.80 $-112.24 0.00
2016-12-31 183.15 $-112.04 0.00
2022-03-31 587.56 $-110.92 0.00
2016-09-30 162.52 $3.33 48.80
2016-06-30 141.99 $3.30 43.03
2016-03-31 135.03 $3.66 36.89
2015-12-31 137.68 $3.85 35.76
2015-09-30 132.79 $3.51 37.83
2015-06-30 146.50 $3.31 44.26
2015-03-31 135.00 $3.43 39.36
2014-12-31 120.51 $3.05 39.51
2014-09-30 115.55 $2.75 42.02
2014-06-30 123.45 $2.11 58.51
2014-03-31 127.95 $2.22 57.64
2013-12-31 123.71 $2.67 46.33
2013-09-30 118.00 $3.28 35.98
2013-06-30 113.00 $5.01 22.55
2013-03-31 122.25 $5.50 22.23
2012-12-31 104.08 $5.91 17.61
2012-09-30 108.61 $6.34 17.13
2012-06-30 100.33 $6.47 15.51
2012-03-31 103.42 $6.19 16.71
2011-12-31 95.31 $7.51 12.69
2011-09-30 90.10 $7.02 12.83
2011-06-30 117.87 $6.76 17.44
2010-12-31 104.57 $6.59 15.87
2010-09-30 91.05 $5.53 16.46
2010-06-30 87.25 $5.10 17.11
2010-03-31 103.14 $5.13 20.11
2009-12-31 97.86 $5.26 18.60
2011-03-31 118.57 $5.01 23.67
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $12.069B $2.923B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $170.688B 10.41
GSK (GSK) United Kingdom $70.345B 8.82
QIAGEN (QGEN) Netherlands $11.249B 19.20
Ginkgo Bioworks Holdings (DNA) United States $3.861B 0.00
Myovant Sciences (MYOV) United Kingdom $2.600B 0.00
Arcus Biosciences (RCUS) United States $2.547B 38.23
Biohaven (BHVN) United States $1.078B 0.00
Emergent Biosolutions (EBS) United States $0.614B 4.82
Zymeworks (ZYME) Canada $0.486B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.281B 0.00
Enzo Biochem (ENZ) United States $0.097B 0.00
SQZ Biotechnologies (SQZ) United States $0.074B 0.00
Gelesis Holdings (GLS) United States $0.027B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00